We are live on ! Find out more
CL

CSS LLC Portfolio holdings

AUM $2.09B
1-Year Est. Return 59.56%
This Fund
S&P 500
This Quarter Est. Return
-5.38%
1 Year Est. Return
+59.56%
3 Year Est. Return
+106.78%
5 Year Est. Return
+137.14%
10 Year Est. Return
+420.84%
AUM
$2.45B
AUM Growth
-$310M
Cap. Flow
-$621M
Cap. Flow %
-25.32%
Top 10 Hldgs %
23.6%
Holding
1,465
New
309
Increased
300
Reduced
222
Closed
375
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLDPW icon
801
Solid Power Inc Warrant
SLDPW
$6.59M
$95K ﹤0.01%
+88,643
New +$156K
UWMC icon
802
CALL
UWM Holdings
UWMC
$631M
$95K ﹤0.01%
27,100
AUPH icon
803
CALL
Aurinia Pharmaceuticals
AUPH
$1.92B
$92K ﹤0.01%
9,200
-1,500
-14% -$16.8K
ZIM icon
804
PUT
ZIM Integrated Shipping Services
ZIM
$2.9B
$90K ﹤0.01%
1,900
-29,400
-94% -$1.73M
FFAIW
805
DELISTED
Faraday Future Intelligent Electric Warrant
FFAIW
$86K ﹤0.01%
183,899
ARCH
806
PUT
DELISTED
Arch Resources, Inc.
ARCH
$86K ﹤0.01%
+600
New +$95.5K
VKTX icon
807
Viking Therapeutics
VKTX
$3.93B
$85K ﹤0.01%
29,258
AMC icon
808
AMC Entertainment Holdings
AMC
$2.38B
$84K ﹤0.01%
620
HRTX icon
809
Heron Therapeutics
HRTX
$91.9M
$84K ﹤0.01%
30,000
LSXMA
810
CALL
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$83K ﹤0.01%
+3,130
New +$93.7K
BTAI icon
811
BioXcel Therapeutics
BTAI
$26.1M
$82K ﹤0.01%
391
-1,415
-78% -$298K
CHNG
812
CALL
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$81K ﹤0.01%
3,500
OCUL icon
813
CALL
Ocular Therapeutix
OCUL
$1.85B
$80K ﹤0.01%
+20,000
New +$75.6K
CVNA icon
814
Carvana
CVNA
$47.3B
$79K ﹤0.01%
17,500
-6,500
-27% -$68.4K
NKLA
815
DELISTED
Nikola Corporation Common Stock
NKLA
$77K ﹤0.01%
540
AEF
816
abrdn Emerging Markets Equity Income Fund
AEF
$341M
$76K ﹤0.01%
13,821
-3,811
-22% -$22.4K
MNTSW icon
817
Momentus Inc Warrant
MNTSW
$136
$76K ﹤0.01%
246,208
+61,287
+33% +$28.4K
BNTX icon
818
BioNTech
BNTX
$23.4B
$75K ﹤0.01%
500
HRTX icon
819
PUT
Heron Therapeutics
HRTX
$91.9M
$74K ﹤0.01%
+26,500
New +$106K
QVCGB
820
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$74K ﹤0.01%
386
-81
-17% -$18.6K
APTO
821
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
$74K ﹤0.01%
222
BOXD
822
PUT
DELISTED
Boxed, Inc.
BOXD
$74K ﹤0.01%
+40,000
New +$309K
CANO.WS
823
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$72K ﹤0.01%
+105,860
New +$110K
CRDF icon
824
Cardiff Oncology
CRDF
$63.4M
$70K ﹤0.01%
31,994
AYLA
825
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$70K ﹤0.01%
64,180
+31,878
+99% +$72.8K

Similar funds

CSS LLC's Q2 2022 Portfolio in Review

As of Q2 2022, CSS LLC held 1,465 positions worth $2.45B, down 11% from $2.76B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

CSS LLC withdrew a net $621M in Q2 2022, closing 375 positions and reducing 222 holdings. Its most notable exit was Essential Utilities, Inc.6.00% Tangible Equity Units, an estimated $31.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 14% a quarter earlier, followed by Energy and Healthcare.

Against the trend, CSS LLC opened a new position in Oklo worth $4.97M.

  • CSS LLC's largest Q2 2022 buy was Oklo: 515,260 shares worth $4.97M.
  • CSS LLC added most to Noble Corp in Q2 2022, an estimated $33.5M increase.
  • CSS LLC's biggest Q2 2022 reduction was AT&T, cutting an estimated $27.1M.
  • CSS LLC fully exited Essential Utilities, Inc.6.00% Tangible Equity Units in Q2 2022, selling an estimated $31.6M.
  • CSS LLC's ten largest holdings make up 24% of its $2.45B portfolio in Q2 2022.
  • CSS LLC opened 309 new positions and closed 375 in Q2 2022.
  • CSS LLC's portfolio value fell 11% quarter-over-quarter to $2.45B.

Based on CSS LLC's 13F filing for Q2 2022, filed 15 Aug 2022.